Jean-louis L. Misset

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

To Treat or Not to Treat Metastatic Cancer Patients with Poor Performance Status: a Prospective Experience.

To Treat or Not to Treat Metastatic Cancer Patients with Poor Performance Status: a Prospective Experience.

Journal: Pathology oncology research : POR

Published: August 30, 2015

A phase II study of afatinib, an irreversible ErbB family blocker, added to letrozole in patients with estrogen receptor-positive hormone-refractory metastatic breast cancer progressing on letrozole.

A phase II study of afatinib, an irreversible ErbB family blocker, added to letrozole in patients with estrogen receptor-positive hormone-refractory metastatic breast cancer progressing on letrozole.

Journal: SpringerPlus

Published: February 12, 2015

Prospective Clinical Utility Study of the Use of the 21-Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor-Positive Early Invasive Breast Cancer: Results From the SWITCH Study.

Prospective Clinical Utility Study of the Use of the 21-Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor-Positive Early Invasive Breast Cancer: Results From the SWITCH Study.

Journal: The oncologist

Published: December 09, 2014

¹⁸F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer.

¹⁸F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer.

Journal: European journal of radiology

Published: March 01, 2014

History of medical oncology

History of medical oncology

Journal: Bulletin du cancer

Published: July 18, 2013

Phase I study of BIBF 1120 with docetaxel and prednisone in metastatic chemo-naive hormone-refractory prostate cancer patients.

Phase I study of BIBF 1120 with docetaxel and prednisone in metastatic chemo-naive hormone-refractory prostate cancer patients.

Journal: British journal of cancer

Published: October 27, 2011

Phase I and pharmacokinetic study of the multitargeted antifolate pemetrexed in combination with oxaliplatin in patients with advanced solid tumors.

Phase I and pharmacokinetic study of the multitargeted antifolate pemetrexed in combination with oxaliplatin in patients with advanced solid tumors.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: June 19, 2004

Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients.

Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 03, 2004

Multicenter phase II-III study of oxaliplatin plus cyclophosphamide vs. cisplatin plus cyclophosphamide in chemonaive advanced ovarian cancer patients.

Multicenter phase II-III study of oxaliplatin plus cyclophosphamide vs. cisplatin plus cyclophosphamide in chemonaive advanced ovarian cancer patients.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: January 05, 2002

Showing 1-9 of 9

Last Updated: 09/26/2026